1-156135913-G-T
Variant summary
Our verdict is Pathogenic. Variant got 11 ACMG points: 11P and 0B. PVS1PM2PP5
The NM_170707.4(LMNA):c.949G>T(p.Glu317*) variant causes a stop gained change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.000000684 in 1,461,384 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (no stars). Synonymous variant affecting the same amino acid position (i.e. E317E) has been classified as Likely benign. Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_170707.4 stop_gained
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 11 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
LMNA | NM_170707.4 | c.949G>T | p.Glu317* | stop_gained | 6/12 | ENST00000368300.9 | NP_733821.1 | |
LMNA | NM_005572.4 | c.949G>T | p.Glu317* | stop_gained | 6/10 | ENST00000677389.1 | NP_005563.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
LMNA | ENST00000368300.9 | c.949G>T | p.Glu317* | stop_gained | 6/12 | 1 | NM_170707.4 | ENSP00000357283.4 | ||
LMNA | ENST00000677389.1 | c.949G>T | p.Glu317* | stop_gained | 6/10 | NM_005572.4 | ENSP00000503633.1 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome AF: 6.84e-7 AC: 1AN: 1461384Hom.: 0 Cov.: 34 AF XY: 0.00000138 AC XY: 1AN XY: 726994
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
not provided Pathogenic:1
Pathogenic, no assertion criteria provided | clinical testing | Stanford Center for Inherited Cardiovascular Disease, Stanford University | Jun 14, 2013 | Note this variant was found in clinical genetic testing performed by one or more labs who may also submit to ClinVar. Thus any internal case data may overlap with the internal case data of other labs. The interpretation reviewed below is that of the Stanford Center for Inherited Cardiovascular Disease. LMNA p.Glu317Ter This variant is novel, it has not been reported in peer reviewed literature to date. This nucleotide substitution is expected to create a premature stop codon and a truncated Lamin A/C protein. There are at least 10 different nonsense variants reported in the LMNA gene associated with various phenotypes, primarily dilated cardiomyopathy, conduction system disease, or muscular dystrophy (LGMD, EDMD) (Cowan J et al 2011, http://www.dmd.nl/lmna_seqvar.html). Geiger et al (2007) report a nearby nonsense variant (R321X) in a family with DCM and sudden death; three affected family members were genotyped and they all had the variant. mRNA and protein studies on patient skin fibroblasts and LV myocardium were consistent with mRNA mediated nonsense decay. Van Engelen et al (2005) reported another nonsense variant, p.Tyr259Ter segregating with limb-girdle muscular dystrophy in nine affected family members. A homozygous baby born to consanguineous heterozygous parents died at birth because of severe generalized muscular dystrophy. The variant is not listed in dbSNP or 1000 genomes (as of September 2011). No nonsense variants were identified in 47 healthy elderly individuals studied by Halaschek-Wiener et al (2009). This variant was not present in the NHLBI exome sequencing project data on LMNA, which includes variant calls on ~6500 individuals of European and African American descent (and, of note, there are currently no frameshift or nonsense variants in control individuals in this dataset, as of 6/14/2013). LMNA variants are frequently associated with dilated cardiomyopathy and conduction system disease. Patients with Emery-Dreifuss muscular dystrophy associated with LMNA variants have been reported with either dilated cardiomyopathy or a restrictive cardiomyopathy (Raffaele di Barletta et al 2000, Sanna et al 2003). However, we have not been able to find any cases of isolated restrictive cardiomyopathy due to LMNA variants. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at